{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:51:38Z","timestamp":1793962298866,"version":"4.8.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes (EFSD)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.biopha.2018.03.144","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T01:29:57Z","timestamp":1522978197000},"page":"833-838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin ameliorates retinal endothelial cell dysfunction triggered by inflammation"],"prefix":"10.1016","volume":"102","author":[{"given":"Andreia","family":"Gon\u00e7alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00edsa","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Fontes-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio F.","family":"Ambr\u00f3sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Crist\u00f3v\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.03.144_bib0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0070-2153(01)52010-4","article-title":"Cell-cell interactions in vascular development","volume":"52","author":"Darland","year":"2001","journal-title":"Curr. Top. Dev. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2018.03.144_bib0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10456-007-9065-1","article-title":"Development of the retinal vasculature","volume":"10","author":"Fruttiger","year":"2007","journal-title":"Angiogenesis"},{"issue":"4","key":"10.1016\/j.biopha.2018.03.144_bib0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1006\/exer.1997.0365","article-title":"Development of the human retinal vasculature: cellular relations and VEGF expression","volume":"65","author":"Provis","year":"1997","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.03.144_bib0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/diacare.21.1.143","article-title":"Diabetic retinopathy","volume":"21","author":"Aiello","year":"1998","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.biopha.2018.03.144_bib0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra021678","article-title":"Diabetic retinopathy","volume":"350","author":"Frank","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.03.144_bib0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nm0207-131","article-title":"A prize catch for diabetic retinopathy","volume":"13","author":"Gardner","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.03.144_bib0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/db10-0454","article-title":"Diabetic retinopathy: targeting vasoregression","volume":"60","author":"Hammes","year":"2011","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.biopha.2018.03.144_bib0040","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"Diabetic retinopathy: seeing beyond glucose-induced microvascular disease","volume":"55","author":"Antonetti","year":"2006","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.biopha.2018.03.144_bib0045","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00417-008-0868-6","article-title":"Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes--role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy","volume":"246","author":"Adamiec-Mroczek","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"7","key":"10.1016\/j.biopha.2018.03.144_bib0050","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.2337\/db10-0110","article-title":"Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy","volume":"59","author":"Schwartzman","year":"2010","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.biopha.2018.03.144_bib0055","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.2337\/db09-1606","article-title":"TNF-alpha signals through PKCzeta\/NF-kappaB to alter the tight junction complex and increase retinal endothelial cell permeability","volume":"59","author":"Aveleira","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.03.144_bib0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mvr.2013.06.007","article-title":"Inflammatory cytokine-specific alterations in retinal endothelial cell function","volume":"89","author":"Palenski","year":"2013","journal-title":"Microvasc. Res."},{"issue":"6865","key":"10.1016\/j.biopha.2018.03.144_bib0065","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2018.03.144_bib0070","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1167\/iovs.11-9291","article-title":"Glucosamine modulates TNF-alpha-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells","volume":"53","author":"Chen","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2018.03.144_bib0075","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0002-9440(10)64332-5","article-title":"Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor","volume":"162","author":"El-Remessy","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.biopha.2018.03.144_bib0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"Tang","year":"2011","journal-title":"Prog. Retin Eye Res."},{"issue":"2","key":"10.1016\/j.biopha.2018.03.144_bib0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/0975-3583.83035","article-title":"Inflammation and diabetic retinal microvascular complications","volume":"2","author":"Zhang","year":"2011","journal-title":"J. Cardiovasc. Dis. Res."},{"key":"10.1016\/j.biopha.2018.03.144_bib0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.preteyeres.2015.04.003","article-title":"Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence","volume":"48","author":"Simo","year":"2015","journal-title":"Prog. Retin Eye Res."},{"issue":"9","key":"10.1016\/j.biopha.2018.03.144_bib0095","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.bbadis.2014.04.013","article-title":"Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats","volume":"1842","author":"Goncalves","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.biopha.2018.03.144_bib0100","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1463-1326.2011.01548.x","article-title":"Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model","volume":"14","author":"Goncalves","year":"2012","journal-title":"Diabetes Obes. Metab."},{"issue":"26","key":"10.1016\/j.biopha.2018.03.144_bib0105","doi-asserted-by":"crossref","first-page":"27219","DOI":"10.1074\/jbc.M400446200","article-title":"High glucose down-regulates intercellular communication in retinal endothelial cells by enhancing degradation of connexin 43 by a proteasome-dependent mechanism","volume":"279","author":"Fernandes","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2018.03.144_bib0110","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1167\/iovs.15-19006","article-title":"Protective effect of a GLP-1 analog on ischemia-reperfusion induced blood-retinal barrier breakdown and inflammation","volume":"57","author":"Goncalves","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2018.03.144_bib0115","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.biopha.2018.03.144_bib0120","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s12035-014-8973-5","article-title":"Acetyl-L-carnitine prevents methamphetamine-induced structural damage on endothelial cells via ILK-related MMP-9 activity","volume":"53","author":"Fernandes","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.biopha.2018.03.144_bib0125","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3109\/02713683.2010.510257","article-title":"Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy","volume":"35","author":"Oh","year":"2010","journal-title":"Curr. Eye Res."},{"issue":"5","key":"10.1016\/j.biopha.2018.03.144_bib0130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1056-8727(01)00155-6","article-title":"Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy","volume":"15","author":"Yuuki","year":"2001","journal-title":"J. Diabetes Complications"},{"issue":"11","key":"10.1016\/j.biopha.2018.03.144_bib0135","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1167\/iovs.10-5264","article-title":"Effects of ischemic preconditioning and bevacizumab on apoptosis and vascular permeability following retinal ischemia-reperfusion injury","volume":"51","author":"Abcouwer","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2018.03.144_bib0140","doi-asserted-by":"crossref","first-page":"872978","DOI":"10.1155\/2012\/872978","article-title":"Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy","volume":"2012","author":"Simo-Servat","year":"2012","journal-title":"Mediators Inflamm."},{"issue":"3","key":"10.1016\/j.biopha.2018.03.144_bib0145","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/jcbfm.2013.230","article-title":"Ischemia-reperfusion injury induces occludin phosphorylation\/ubiquitination and retinal vascular permeability in a VEGFR-2-dependent manner","volume":"34","author":"Muthusamy","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.biopha.2018.03.144_bib0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1742-2094-10-149","article-title":"Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury","volume":"10","author":"Abcouwer","year":"2013","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.biopha.2018.03.144_bib0155","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db09-1694","article-title":"Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4","volume":"59","author":"Arakawa","year":"2010","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.biopha.2018.03.144_bib0160","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2337\/diabetes.54.5.1559","article-title":"Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy","volume":"54","author":"Krady","year":"2005","journal-title":"Diabetes"},{"issue":"19","key":"10.1016\/j.biopha.2018.03.144_bib0165","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.96.19.10836","article-title":"Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition","volume":"96","author":"Miyamoto","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2018.03.144_bib0170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.exer.2014.05.004","article-title":"Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats","volume":"127","author":"Fan","year":"2014","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.03.144_bib0175","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db15-0443","article-title":"Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in ExperimentalDiabetes","volume":"65","author":"Hernandez","year":"2016","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.biopha.2018.03.144_bib0180","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1007\/s00125-017-4388-y","article-title":"Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes","volume":"60","author":"Hernandez","year":"2017","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.biopha.2018.03.144_bib0185","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1210\/er.2014-1035","article-title":"Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors","volume":"35","author":"Mulvihill","year":"2014","journal-title":"Endocr. Rev."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221830711X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221830711X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T16:04:54Z","timestamp":1731427494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221830711X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":37,"alternative-id":["S075333221830711X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.03.144","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin ameliorates retinal endothelial cell dysfunction triggered by inflammation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.03.144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}